日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Effectiveness of Tofacitinib in Patients with Psoriatic Arthritis Initiating Monotherapy Versus Combination Therapy: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

托法替尼单药治疗与联合治疗在银屑病关节炎患者中的疗效比较：来自CorEvitas银屑病关节炎/脊柱关节炎注册研究的结果

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-025-00811-4
Ogdie, Alexis; Middaugh, Nicole; Blachley, Taylor; Bourgeois, Tran; Ling, You-Li; Mundayat, Rajiv; Fallon, Lara; Masri, Karim R; Mease, Philip J
关节炎
银屑病
发表日期：2026
文献求助 收藏

Quantifying Disease Activity Despite Treatment with Tumor Necrosis Factor Inhibitors Among Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Real-World Results from the PPD CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

量化接受肿瘤坏死因子抑制剂治疗的银屑病关节炎和中轴型脊柱关节炎患者的疾病活动度：来自 PPD CorEvitas 银屑病关节炎/脊柱关节炎注册研究的真实世界结果

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-025-00813-2
Mease, Philip; Ye, Xiaolan; Saffore, Christopher D; Parikh, Bhumik; Ciecinski, Sandra; Blachley, Taylor; Eliot, Melissa; Middaugh, Nicole; Ogdie, Alexis
关节炎
银屑病
肿瘤免疫
肿瘤
发表日期：2026
文献求助 收藏

Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

托法替尼治疗银屑病关节炎患者的疗效：来自CorEvitas银屑病关节炎/脊柱关节炎注册研究的结果

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-023-00631-4
Mease, Philip J; Young, Pamela; Fallon, Lara; Mundayat, Rajiv; Dina, Oluwaseyi; Blachley, Taylor; Middaugh, Nicole; Ogdie, Alexis
关节炎
银屑病
发表日期：2024
文献求助 收藏

Disparities in burden of disease in patients with rheumatoid arthritis across racial and ethnic groups

不同种族和族裔群体中类风湿性关节炎患者的疾病负担存在差异

期刊:Clinical Rheumatology
影响因子:2.8
doi:10.1007/s10067-024-06869-9
O'Brien, Jacqueline; Park, Sang Hee; Blachley, Taylor; Marchese, Maya; Middaugh, Nicole; Wittstock, Keith; Harrold, Leslie R
关节炎
发表日期：2024
文献求助 收藏

A Real-World Effectiveness Study Using a Mobile Application to Evaluate Early Outcomes with Upadacitinib in Rheumatoid Arthritis

一项利用移动应用程序评估乌帕替尼治疗类风湿性关节炎早期疗效的真实世界有效性研究

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-023-00594-6
Harrold, Leslie R; Zueger, Patrick; Nowell, W Benjamin; Blachley, Taylor; Schrader, Amy; Lakin, Paul R; Curtis, David; Stradford, Laura; Venkatachalam, Shilpa; Tundia, Namita; Patel, Pankaj A
关节炎
发表日期：2023
文献求助 收藏

Clinical Outcomes in Patients with Rheumatoid Arthritis After Switching Between Interleukin-6-Receptor Inhibitors and Janus Kinase Inhibitors: Findings from an Observational Study

类风湿性关节炎患者在白细胞介素-6受体抑制剂和Janus激酶抑制剂之间转换治疗后的临床结局：一项观察性研究的结果

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-023-00609-2
Dua, Anisha B; Ford, Kerri; Fiore, Stefano; Pappas, Dimitrios A; Janak, Jud C; Blachley, Taylor; Roberts-Toler, Carla; Emeanuru, Kelechi; Kremer, Joel M; Kivitz, Alan
信号转导
关节炎
细胞生物学
发表日期：2023
文献求助 收藏

Comparative effectiveness of TNF inhibitor vs IL-6 receptor inhibitor as monotherapy or combination therapy with methotrexate in biologic-experienced patients with rheumatoid arthritis: An analysis from the CorEvitas RA Registry

在既往接受过生物制剂治疗的类风湿关节炎患者中，TNF抑制剂与IL-6受体抑制剂作为单药治疗或与甲氨蝶呤联合治疗的疗效比较：来自CorEvitas RA注册研究的分析

期刊:Clinical Rheumatology
影响因子:2.8
doi:10.1007/s10067-023-06588-7
Sebba, Anthony; Bingham, Clifton O; Bykerk, Vivian P; Fiore, Stefano; Ford, Kerri; Janak, Jud C; Pappas, Dimitrios A; Blachley, Taylor; Dave, Swapna S; Kremer, Joel M; Yu, Miao; Choy, Ernest
信号转导
关节炎
IL-6
发表日期：2023
文献求助 收藏

The effect of targeted rheumatoid arthritis therapeutics on systemic inflammation and anemia: analysis of data from the CorEvitas RA registry

靶向类风湿关节炎治疗对全身炎症和贫血的影响：来自 CorEvitas RA 注册研究的数据分析

期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-022-02955-y
Padula, Anthony S; Pappas, Dimitrios A; Fiore, Stefano; Blachley, Taylor S; Ford, Kerri; Emeanuru, Kelechi; Kremer, Joel M
炎症
炎症/感染
代谢
关节炎
贫血
发表日期：2022
文献求助 收藏

Treatment Responses in Patients With Psoriatic Arthritis Axial Disease According to Human Leukocyte Antigen-B27 Status: An Analysis From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

根据人类白细胞抗原-B27状态对银屑病关节炎中轴型疾病患者的治疗反应进行分析：来自CorEvitas银屑病关节炎/脊柱关节炎注册研究的分析

期刊:ACR Open Rheumatology
影响因子:2.8
doi:10.1002/acr2.11416
Mease, Philip J; Chakravarty, Soumya D; McLean, Robert R; Blachley, Taylor; Kawashima, Toana; Lin, Iris; Kavanaugh, Arthur; Ogdie, Alexis
关节炎
银屑病
Human
细胞生物学
发表日期：2022
文献求助 收藏

Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study

一线肿瘤坏死因子抑制剂与非肿瘤坏死因子抑制剂生物制剂和靶向合成药物在类风湿性关节炎患者中的疗效比较：一项大型美国注册研究的结果

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/annrheumdis-2020-217209
Pappas, Dimitrios A; St John, Gregory; Etzel, Carol J; Fiore, Stefano; Blachley, Taylor; Kimura, Toshio; Punekar, Rajeshwari; Emeanuru, Kelechi; Choi, Jeannie; Boklage, Susan; Kremer, Joel M
关节炎
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏